welcome to cyprotex

News

March 2, 2010 - Rule 2.10 Announcement

Cyprotex PLC

(“Cyprotex” or the “Company”)

Rule 2.10 Announcement

Pursuant to Rule 2.10 of the City Code on Mergers and Acquisitions (the "Code"), Cyprotex confirms that it has 178,957,188 ordinary shares of 0.1p each ("Ordinary Shares"), in issue and admitted to trading on the AIM market of the London Stock Exchange. The International Securities Identification Number for the ordinary shares is GB0031214470.
Rule 19.11 disclosure

In accordance with Rule 19.11 of the Code, a copy of this Announcement will be published on the Cyprotex website: www.cyprotex.com.

Enquiries:

Cyprotex PLC
Anthony Baxter CEO
01625 505100
ir@cyprotex.com
www.cyprotex.com

Execution Noble & Company Limited
John Llewellyn-Lloyd / Sam Reynolds
020 7456 9191

Public Relations
Financial Dynamics
Ben Brewerton / Ben Atwell / John Dineen
020 7831 3113

view all the latest news +
2009 archive +
2008 archive +
2007 archive +
2006 archive +
2005 archive +
2004 archive +
2003 archive +
2002 archive +
contact

Contact us for more information on Cyprotex Discovery, including our extensive range of ADMET/PK services
and pricing.

contact
careerscontactlegalprivacy
This website was last updated
on 8th September 2010
This website is intended to assist investors, industry participants, customers and employees to understand Cyprotex’s global operations and ambitions.
Certain information and detail is disclosed in the interest of compliance of AIM Rule 26.